Pylos Nutraceuticals develops a new treatment to prevent infection by the bacterium Helicobacter pylori.
Encubator Innovation Project from 2006.
Pylos Nutraceuticals is a project, on its way to become a company, which develops and commercializes a new way to prevent infection by the bacterium Helicobacter pylori. The bacteria adhere to the human stomach lining and causes diseases like ulcers, chronic gastritis and cancer.
Current treatment of inflammation caused by Helicobacter pylori infection is based on different antibiotics in combination with a gastric juice inhibitor. However, several strains of bacteria resistant to antibiotics have been reported and needs of alternative treatment methods are growing, specifically preventive ones.
Joseph Andersson
Roland Björkman
Pylos Nutraceuticals is an Encubator Innovation Project from GIBBS class of 2006.
Biotech
Food & Health Concept Centre
Halina Miller Podraza
+46 730-73 05 02
Vera Sandbergs Allé 8, Gothenburg
